Kazutaka Sunami
14PUBLICATIONS
36CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (14)
Sort by Publication Date:
|Dec 27, 2025
Efficacy and safety of isatuximab subcutaneous plus carfilzomib and dexamethasone in patients with relapsed/refractory multiple myeloma: results of the Phase 2 study IZALCO.Gurdeep Parmar, Marcelo Capra, Fernanda Seguro
|May 09, 2025
Phase 1 study of talquetamab, a humanized GPRC5D x CD3 bispecific antibody, in Japanese patients with relapsed/refractory MM.Shinsuke Iida, Kazutaka Sunami, Shigeki Ito
|Dec 24, 2024
DREAMM-11, Part 2: Japanese phase I trial of belantamab mafodotin combination therapies in relapsed/refractory multiple myeloma.Kazutaka Sunami, Shinsuke Iida, Nobuhiro Tsukada
|Nov 28, 2024
A Phase 1/2 study of teclistamab, a humanized BCMA × CD3 bispecific Ab in Japanese patients with relapsed/refractory MM.Tadao Ishida, Yoshiaki Kuroda, Kosei Matsue
|Mar 18, 2024
Autologous HSCT with novel agent-based induction and consolidation followed by lenalidomide maintenance for untreated multiple myeloma.Yasuo Mori, Jun Takizawa, Yuna Katsuoka
|Sep 25, 2020
Isatuximab monotherapy in relapsed/refractory multiple myeloma: A Japanese, multicenter, phase 1/2, safety and efficacy study.Kazutaka Sunami, Kenshi Suzuki, Masaki Ri
Pageof 3
Frequent Collaborators
3 joint publications
Shinsuke Iida
2 joint publications
Junichiro Yuda
2 joint publications
Tadao Ishida
1 joint publications
Takehiko Mori
1 joint publications
Kosei Matsue
1 joint publications
Masaki Ri
1 joint publications
Dai Maruyama
1 joint publications
Kana Miyazaki
1 joint publications
Hang Quach
1 joint publications
Kohta Miyawaki
